1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Real-time Zero Trust Data and Access Control for Combat Systems" is currently closed and not accepting applications.
Real-time Zero Trust Data and Access Control for Combat Systems is sponsored by Department of Defense (DoD), Department of the Navy. The Navy relies on combat system data for critical decision-making in wartime. This topic focuses on developing real-time zero trust data and access control solutions to prevent unauthorized access to this data.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Small businesses. Confirm the full requirements in the official notice before applying.
The published deadline was July 22, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Real-time Zero Trust Data and Access Control for Combat Systems is funded by Department of Defense (DoD), Department of the Navy. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) is sponsored by Defense Health Agency Contracting Activity - DHACA. This award supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to improved patient outcomes, with a focus on well-formulated, testable hypotheses and strong scientific rationale.
Pancreatic Cancer Research Program (PCARP) Patient-Centered Focus Area Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP), Department of Defense. This award supports the exploration and development of impactful and innovative concepts under a patient-centered focus that could ultimately lead to major advancements in patients' overall quality of life.
FY26 Rare Cancers Research Program (RCRP) Concept Award is sponsored by Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). This award supports the initial exploration of highly innovative, untested, potentially ground-breaking novel concepts in rare cancers. The potential impact may be near-term or long-term but must move beyond a minor advancement and demonstrate the potential to lead to a fundamentally new strategy or approach. Must address focus areas like Biology, Preclinical Research Model, Therapy, or AI/ML Model.
The Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article